Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,622 followers.

RT @FrontCVMedicine: New Research: Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction:…

27 Aug 2022

Reply Repost Favourite

New Research: Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis: Background The angiotensin-receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be… https://t.co/lhPPr

26 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.